WFSBP Programme 2015

45 / 112

43
WFSBP 2015
Tuesday, 16 June 2015 | Scientific Programme
S-03-002
The role of lipid rafts for antidepressant mediated G-pro-
tein signalling
Mark Rasenick, USA
S-03-003
The role of p-glycoprotein for the effects of antidepressants
on HPA axis
Carmine Pariante, United Kingdom
S-03-004
The cytoskeleton as a target for antidepressants
Massimiliano Bianchi, Ireland
T40: Schizophrenia: Basic / Clinical
S-20 Symposium
08:30–10:00 MC 2 Room
Nitric oxide, glutamate and schizophrenia: New insights
Chair: Dragos Inta, Germany
Co-Chair: Andreas Reif, Germany
S-20-001
Nitric oxide and zinc levels in limbic regions in pre- and
post-pubertal rats after neonatal lesions of the ventral hip-
pocampus
Gonzalo Flores, Mexico
S-20-002
NOS1-NOS1AP interaction at the glutamatergic post-sy­
napse as a candidate mechanism in the pathogenesis of
schizophrenia
Andreas Reif, Germany
S-20-003
The glutamate receptor complex in schizophrenia patho-
genesis and treatment
David Bredt, USA
S-20-004
The islands of calleja: The substrate for the glutamate-nitric
oxide-dopamine link in schizophrenia?
Dragos Inta, Germany
A. Meyer-Lindenberg, P. Gass
T6: Bipolar Disorders: Basic/ Clinical
S-21 Symposium
11:00–12:30 Mitropoulos Hall
CANMAT clinical guidelines for bipolar disorders 2013:
The evolution continues
Chair: Lakshmi Yatham, Canada
Co-Chair: Roumen Milev, Canada
S-21-001
Guidelines for clinical practice in bipolar disorders? Over-
view of the field
Konstantinos Fountoulakis, Greece
S-21-002
CANMAT‘s role in developing and implementing guidelines
for clinical practice
Sagar Parikh, Canada
S-21-003
CANMAT/ISBD guidelines: 2013 update
Roumen Milev, Canada
R. Milev
S-21-004
The future of CANMAT/ISBD guidelines
Lakshmi Yatham, Canada
T20: Molecular Neurobiology
S-22 Symposium
11:00–12:30 Skalkotas Hall
Biomarkers in psychiatric disorders
Chair: Peter Riederer, Germany
Co-Chair: Florence Thibaut, France
S-22-001
Biomarkers in schizophrenia
Peter Falkai, Germany
S-22-002
Biomarkers in ADHD
Edna Grünblatt, Switzerland
S-22-003
Biomarkers in alcoholism
Toshikazu Saito, Japan
S-22-004
Biomarkers in Alzheimer‘s disease
Markus Schwarz, Germany
T13: Epidemiology
S-23 Symposium
11:00–12:30 MC 2 Room
Latency to pharmacological treatments in psychiatric dis-
orders: Epidemiological, biological and clinical aspects
Chair: Carlo Altamura, Italy
S-23-002
Assessing latency to pharmacological treatments in psychi-
atric disorders: Differences between affective and psychotic
disorders
Bernardo Dell´Osso, Italy
S-23-003
Immunological findings in relation to untreated schizo-
phrenia
Elif Weidinger, Germany